Skip to main content
. 2024 Mar 14;17:1011–1019. doi: 10.2147/IDR.S452347

Table 1.

Demographic characteristics and clinical features of PB and non-PB children with severe adenovirus pneumonia at admission

Total, n=156 PB group, n=18 Non-PB group, n=138 P
Demographics
Male, n (%) 100 (64.10) 13 (72.22) 87 (63.04) 0.6031
Female, n (%) 56 (35.90) 5 (27.78) 51 (36.96) 0.6031
Age, months, median (IQR) 24.0 (13.0–48.0) 24.0 (12.5–45.0) 24.0 (13.0–48.0) 0.7361
Age distribution
≤1 year, n (%) 36 (23.07) 5 (27.78) 31 (22.45) 0.5660
1–3 years, n (%) 64 (41.03) 8 (44.44) 56 (40.80) 0.8020
≥3 years, n (%) 56 (35.90) 5 (27.78) 51 (36.95) 0.6031
Allergy history, n (%) 15 (9.62) 6 (33.33) 9 (6.52) 0.0027*
Clinical symptoms and signs
Fever, n (%) 156 (100) 18 (100) 138 (100) >0.9999
Fever duration, days, median (IQR) 13.0 (10.0–18.0) 12.5 (10.0-16.0) 13.0 (9.0–18.0) 0.6112
Cough, n (%) 156 (100) 18 (1000) 138 (100) >0.9999
Wheeze, n (%) 49 (31.41) 4 (22.22) 45 (32.61) 0.4320
Shortness of breath, n (%) 88 (56.41) 11 (61.11) 77 (55.80) 0.8022
Hypoxia, n (%) 52 (33.33) 10 (55.56) 41 (29.71) 0.0348*
Gastrointestinal symptoms, n (%) 40 (25.64) 7 (38.89) 33 (23.91) 0.2483
Neurological symptoms, n (%) 19 (12.18) 5 (27.78) 14 (10.14) 0.0476*
Diminished breath sounds, n (%) 47 (30.13) 14 (77.78) 33 (23.91) <0.0001*
Moist rales, n (%) 91 (58.33) 10 (55.56) 81 (58.70) 0.8047
Hepatomegaly or splenomegaly, n (%) 25 (16.03) 4 (22.22) 21 (15.22) 0.4935

Note: *P<0.05.